NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $228,151 | -95.8% | 14,127 | -89.1% | 0.00% | -100.0% |
| Q2 2023 | $5,381,804 | -56.0% | 129,682 | -36.2% | 0.00% | -57.1% |
| Q1 2023 | $12,221,410 | -21.5% | 203,216 | -4.3% | 0.01% | -22.2% |
| Q4 2022 | $15,573,233 | -4.6% | 212,314 | -1.2% | 0.01% | -10.0% |
| Q3 2022 | $16,323,000 | +11.0% | 214,849 | +1.5% | 0.01% | +25.0% |
| Q2 2022 | $14,709,000 | -19.0% | 211,622 | -3.5% | 0.01% | 0.0% |
| Q1 2022 | $18,170,000 | +15.9% | 219,326 | +5.0% | 0.01% | +14.3% |
| Q4 2021 | $15,681,000 | -40.0% | 208,855 | -7.2% | 0.01% | -41.7% |
| Q3 2021 | $26,153,000 | -48.2% | 225,126 | -1.1% | 0.01% | -52.0% |
| Q2 2021 | $50,502,000 | +120.6% | 227,669 | +31.5% | 0.02% | +108.3% |
| Q1 2021 | $22,893,000 | +37.3% | 173,187 | +79.8% | 0.01% | +20.0% |
| Q4 2020 | $16,672,000 | +82.4% | 96,345 | +17.3% | 0.01% | +66.7% |
| Q3 2020 | $9,142,000 | +586.3% | 82,134 | +265.3% | 0.01% | +500.0% |
| Q2 2020 | $1,332,000 | -51.6% | 22,481 | -45.0% | 0.00% | -50.0% |
| Q1 2020 | $2,752,000 | -11.1% | 40,875 | +11.2% | 0.00% | 0.0% |
| Q4 2019 | $3,097,000 | -51.8% | 36,770 | -57.2% | 0.00% | -50.0% |
| Q3 2019 | $6,421,000 | -61.1% | 85,887 | -67.1% | 0.00% | -60.0% |
| Q2 2019 | $16,515,000 | +60.1% | 261,210 | +22.0% | 0.01% | +66.7% |
| Q1 2019 | $10,315,000 | +289.5% | 214,187 | +170.6% | 0.01% | +200.0% |
| Q4 2018 | $2,648,000 | -87.2% | 79,155 | -79.9% | 0.00% | -66.7% |
| Q3 2018 | $20,618,000 | +13.6% | 393,508 | -32.1% | 0.01% | +20.0% |
| Q2 2018 | $18,152,000 | +554.6% | 579,966 | +355.5% | 0.01% | +400.0% |
| Q1 2018 | $2,773,000 | -51.9% | 127,315 | -55.4% | 0.00% | -75.0% |
| Q4 2017 | $5,761,000 | +409.8% | 285,290 | +400.8% | 0.00% | +300.0% |
| Q3 2017 | $1,130,000 | -8.6% | 56,971 | -20.5% | 0.00% | 0.0% |
| Q2 2017 | $1,237,000 | +957.3% | 71,631 | +385.7% | 0.00% | – |
| Q1 2017 | $117,000 | -51.9% | 14,749 | -52.5% | 0.00% | – |
| Q4 2016 | $243,000 | -89.2% | 31,069 | -88.2% | 0.00% | -100.0% |
| Q3 2016 | $2,252,000 | -26.7% | 263,760 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $3,071,000 | -17.4% | 263,262 | +2.6% | 0.00% | -33.3% |
| Q1 2016 | $3,716,000 | +7806.4% | 256,687 | +11985.1% | 0.00% | – |
| Q4 2015 | $47,000 | – | 2,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |